D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PBH holding history
Prestige Consumer Healthcare Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PBH overviewAll 13F holders of PBHFull Q2 2026 holdings
- Shares (Q2 2026)
- 313,778
- Value
- $14.8M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 313,778 | $14.8M | <0.1% | −67,255−17.7% | Reduced | Holders |
| Q1 2026 | 381,033 | $22.6M | <0.1% | −92,104−19.5% | Reduced | Holders |
| Q4 2025 | 473,137 | $29.2M | <0.1% | −64,888−12.1% | Reduced | Holders |
| Q3 2025 | 538,025 | $33.6M | <0.1% | +251,417+87.7% | Added | Holders |
| Q2 2025 | 286,608 | $22.9M | <0.1% | +89,415+45.3% | Added | Holders |
| Q1 2025 | 197,193 | $17.0M | <0.1% | +57,089+40.7% | Added | Holders |
| Q4 2024 | 140,104 | $10.9M | <0.1% | −23,603−14.4% | Reduced | Holders |
| Q3 2024 | 163,707 | $11.8M | <0.1% | +49,775+43.7% | Added | Holders |
| Q2 2024 | 113,932 | $7.84M | <0.1% | +34,153+42.8% | Added | Holders |
| Q1 2024 | 79,779 | $5.79M | <0.1% | −31,594−28.4% | Reduced | Holders |
| Q4 2023 | 111,373 | $6.82M | <0.1% | −14,018−11.2% | Reduced | Holders |
| Q3 2023 | 125,391 | $7.17M | <0.1% | +19,666+18.6% | Added | Holders |
| Q2 2023 | 105,725 | $6.28M | <0.1% | −18,085−14.6% | Reduced | Holders |
| Q1 2023 | 123,810 | $7.75M | <0.1% | +9,494+8.3% | Added | Holders |
| Q4 2022 | 114,316 | $7.16M | <0.1% | −34,675−23.3% | Reduced | Holders |
| Q3 2022 | 148,991 | $7.42M | <0.1% | −77,818−34.3% | Reduced | Holders |
| Q2 2022 | 226,809 | $13.3M | <0.1% | +40,715+21.9% | Added | Holders |
| Q1 2022 | 186,094 | $9.85M | <0.1% | +89,214+92.1% | Added | Holders |
| Q4 2021 | 96,880 | $5.88M | <0.1% | −42,953−30.7% | Reduced | Holders |
| Q3 2021 | 139,833 | $7.85M | <0.1% | −49,864−26.3% | Reduced | Holders |
| Q2 2021 | 189,697 | $9.88M | <0.1% | −88,807−31.9% | Reduced | Holders |
| Q1 2021 | 278,504 | $12.3M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.